Hydroxyamphetamine / tropicamide ophthalmic Pregnancy and Breastfeeding Warnings
Brand names: Paremyd
Hydroxyamphetamine / tropicamide ophthalmic Pregnancy Warnings
This drug should be used during pregnancy only if clearly needed.
US FDA pregnancy category: C
Animal studies have not been reported. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Hydroxyamphetamine / tropicamide ophthalmic Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- (2013) "Product Information. Paremyd (hydroxyamphetamine-tropicamide ophthalmic)." Akorn Inc
References for breastfeeding information
- (2013) "Product Information. Paremyd (hydroxyamphetamine-tropicamide ophthalmic)." Akorn Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.